COMMUNIQUÉS West-GlobeNewswire

Akcea Therapeutics to Hold Second Quarter 2019 Financial Results Webcast
29/07/2019
Webcast scheduled for Tuesday, August 6th at 4:30 p.m. Eastern Time BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that it [...]
Avadel Pharmaceuticals to Report Second Quarter 2019 Financial Results
29/07/2019
DUBLIN, Ireland, July 29, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for narcolepsy, today announced that it will host a conference call and live webcast [...]
Anavex Life Sciences Receives Positive Opinion for Orphan Designation from the European Medicines Agency for ANAVEX®2-73 for the Treatment of Rett Syndrome
29/07/2019
NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer
29/07/2019
NEW HAVEN, Conn., July 29, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, announced today the appointment of Ronald [...]
Protalix BioTherapeutics Appoints Eyal Rubin as its New Senior Vice President and Chief Financial Officer
29/07/2019
CARMIEL, Israel, July 29, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX) today announced that Eyal Rubin has been appointed to serve as the Company’s new Senior Vice President and [...]
European Medicines Agency Grants PRIME Access to ProQR’s Sepofarsen for Leber’s Congenital Amaurosis 10
29/07/2019
Access based on positive interim analysis of clinical data as well as preclinical data to date PRIME designation provides a pathway for frequent and early interactions with the EMA aimed at supporting accelerated [...]
Amicus Therapeutics to Announce Second Quarter 2019 Financial Results on August 8, 2019
29/07/2019
CRANBURY, N.J., July 29, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 8, 2019 at 8:30 a.m. ET to [...]
Axsome Therapeutics Amends Silicon Valley Bank Loan Agreement Increasing Financial Flexibility
29/07/2019
Extends interest-only period and time to access additional funding NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel [...]
Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis in a Recent Idiopathic Pulmonary Fibrosis Study by 56%
29/07/2019
Potential First-in-Class Treatment VANCOUVER, British Columbia, July 29, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical [...]
Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
29/07/2019
Data from second part of successful Phase 2 STRIVE trial further substantiate the efficacy, safety and tolerability of once-weekly rezafungin for first-line treatment of invasive Candida infections Global Phase 3 [...]
Stemline Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results on August 2, 2019
29/07/2019
NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Novo Nordisk A/S – Share repurchase programme
29/07/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 29 July 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European [...]
FDA Accepts IND Application for Cerecor’s Investigational Drug CERC-802 for the treatment of MPI-CDG
29/07/2019
ROCKVILLE, Md., July 29, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
Union Terminal’s Modern Technology Enables a World-Class Experience for Cincinnati Museum Center Visitors
29/07/2019
CINCINNATI, July 29, 2019 (GLOBE NEWSWIRE) -- “Modernization” is not a new concept for 1933-Cincinnati-icon, Union Terminal. From the Art Deco architecture characteristic of the 1920s and -30s to the gravity-defying [...]
Arrayit Corporation Announces Global Expansion of Finger Stick Health and Wellness Testing Services
29/07/2019
Food Sensitivity Testing Now Available in the Philippines Sunnyvale, July 29, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces expansion of its [...]
Online Muslim Mental Health company TherapyLine that aims to Normalize Mental Health services in the Muslim world launches in the UK, Australia and New Zealand this week.
29/07/2019
LONDON, July 29, 2019 (GLOBE NEWSWIRE) -- TherapyLine, the online mobile mental health company for Muslims, launches in three new markets today, UK, Australia and New Zealand, as part of a larger plan to provide [...]
Share buy-back week 30/2019
29/07/2019
Announcement 29 July 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Zealand Pharma announces change in corporate management
29/07/2019
Company announcement – No. 24 / 2019 Zealand Pharma announces change in corporate management Copenhagen, Denmark, July 29, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) announces that Andrew [...]
GENFIT: FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
29/07/2019
FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC) Lille (France), Cambridge (Massachusetts, United States), July 29, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late- [...]

Pages